Tag: ESMINT 2026
Compatible catheter families help streamline thrombectomy procedures
This advertorial, intended only for audiences outside the USA, is sponsored by Johnson & Johnson.
With the introduction of new devices, techniques and clinical data,...
ESMINT welcomes five national organisations to its council of affiliated societies
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has welcomed five additional national societies to its council of affiliated societies through multiple newly...
New meta-analysis highlights need for more comprehensive approach to brain aneurysm...
“We have to be much more comprehensive in our guidance and counselling of these patients,” says Nima Etminan (University Medical Centre Mannheim, Mannheim, Germany),...
Randomised clinical trials are ‘a methodology, not the oracle’
Following a session that saw neurointerventional experts deliberate the best and worst of randomised controlled trials (RCTs) in the field’s recent history, NeuroNews caught...
ESMINT announces new executive board for 2026–2028 term
Earlier this month, at the 18th European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), the society introduced its new...
Tenecteplase-related clot migration does not create a “clinical penalty” for stroke...
At this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (2–4 September, Marseille, France), NeuroNews spoke with Jildaz Caroff (Bicêtre Hospital, Paris,...
MATERNA-X study reveals benefits of radiation shielding during pregnancy
“Protecting the foetus begins with protecting the mother,” was the concluding message delivered by Matthew Zidan (Bonn University Hospital, Bonn, Germany) based on late-breaking...
